BioMarin Pharmaceutical
BMRN
#1829
Rank
โ‚น1.106 T
Marketcap
โ‚น5,725
Share price
-0.92%
Change (1 day)
12.87%
Change (1 year)

BioMarin Pharmaceutical (BMRN) - Net assets

Net assets on the balance sheet as of March 2026 : โ‚น592.57 Billion

According to BioMarin Pharmaceutical's latest financial reports the company has โ‚น592.57 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BioMarin Pharmaceutical - Net assets on balance sheet (from 2001 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$โ‚น546.42 B12.58%
2024-12-31$โ‚น485.37 B17.75%
2023-12-31$โ‚น412.21 B8.22%
2022-12-31$โ‚น380.91 B19.97%
2021-12-31$โ‚น317.49 B5.73%
2020-12-31$โ‚น300.28 B34.86%
2019-12-31$โ‚น222.66 B7.29%
2018-12-31$โ‚น207.52 B15.72%
2017-12-31$โ‚น179.33 B-4.6%
2016-12-31$โ‚น187.98 B17.82%
2015-12-31$โ‚น159.54 B64.76%
2014-12-31$โ‚น96.83 B16.88%
2013-12-31$โ‚น82.84 B48.97%
2012-12-31$โ‚น55.61 B36%
2011-12-31$โ‚น40.89 B27.24%
2010-12-31$โ‚น32.14 B114.99%
2009-12-31$โ‚น14.94 B12.42%
2008-12-31$โ‚น13.29 B80.51%
2007-12-31$โ‚น7.36 B41.21%
2006-12-31$โ‚น5.21 B-249.68%
2005-12-31$-โ‚น3.49 Billion18.4%
2004-12-31$-โ‚น2.95 Billion-154.87%
2003-12-31$โ‚น5.36 B13.55%
2002-12-31$โ‚น4.72 B-38.62%
2001-12-31$โ‚น7.69 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sanofi
SNY
โ‚น8.075 T 1,262.78%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น21.85 Billion-103.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-โ‚น1.81 Billion-100.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚น29.38 Billion-104.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
โ‚น26.15 B-95.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
โ‚น96.60 B-83.70%๐Ÿ‡บ๐Ÿ‡ธ USA